US 12,220,438 B2
Protein based cannabis compositions
Shimon Lecht, Petah Tikva (IL); Olga Gabay, Jerusalem (IL); Adi Lahiani Hafzadi, Jerusalem (IL); and William Z. Levine, Jerusalem (IL)
Assigned to DAY THREE LABS MANUFACTURING INC., Denver, CO (US)
Filed by IZUN PHARMACEUTICALS CORP., New York, NY (US)
Filed on Dec. 31, 2023, as Appl. No. 18/401,503.
Application 18/401,503 is a continuation of application No. 17/638,827, abandoned, previously published as PCT/IL2020/050930, filed on Aug. 26, 2020.
Claims priority of provisional application 62/893,201, filed on Aug. 29, 2019.
Prior Publication US 2024/0131099 A1, Apr. 25, 2024
Int. Cl. A61K 36/185 (2006.01); A61K 31/05 (2006.01); A61K 31/352 (2006.01); A61K 38/01 (2006.01); A61K 47/36 (2006.01)
CPC A61K 36/185 (2013.01) [A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 38/011 (2013.01); A61K 47/36 (2013.01); A61K 2236/35 (2013.01)] 11 Claims
 
1. A method for making an oral dosage form selected from the group consisting of a candy, a chocolate, a cookie, a popsicle, a protein shake powder, a beverage, a beer, a soft drink, an alcoholic beverage, a gummy and a milkshake, the method consisting essentially of non-covalently binding a cannabinoid to a whey protein, consisting essentially of dissolving the cannabinoid in ethanol to form an ethanol solution; and then combining the ethanol solution with an aqueous whey protein to form a cannabinoid-protein complex which is then combined with at least one other excipient to form the dosage form, wherein the complex formed between the cannabinoid and the whey protein is performed using nanoprecipitation or emulsification.